Gregory Martyn

Gregory Martyn is a Post-Doctoral Fellow specializing in Antibody Engineering in the lab of Paul Carter at Genentech since November 2022. Previously, Gregory served as a Scientist at Phenomic from June 2022 to October 2022, focusing on protein production, antibody engineering, and workflow optimization for the Phenomic Therapeutic Pipeline. Gregory completed a Ph.D. in Molecular Genetics at the University of Toronto from 2016 to April 2022, after earning a Master of Science in Cell and Systems Biology at the same institution from 2013 to 2016. Earlier in academic career, Gregory conducted research in critical care and rehabilitation as a Clinical Research Student at University Health Network and as a Research Student at the University of Toronto in 2012. Gregory holds a Bachelor of Science in Medical Cell Biology and Genetics from Western University, obtained in 2013.